UNIVERSAL HEALTH SERVICES Reports FY2023 Q2 Earnings Results on June 30, 2023

August 9, 2023

🌥️Earnings Overview

On June 30 2023, UNIVERSAL HEALTH SERVICES ($NYSE:UHS) reported their FY2023 Q2 earnings results. The company saw total revenue of USD 3548.1 million, a 6.8% growth from the same period last year. Net income increased by 4.4% year-over-year to USD 171.3 million.

Market Price

On Wednesday, June 30, 2023, UNIVERSAL HEALTH SERVICES reported their fiscal year 2022 second quarter earnings results, causing their stock to drop by 5.5% from the prior closing price of 149.6 to 141.4. The stock opened at 143.9 in the morning and then steadily declined throughout the day as investors reacted to the quarterly report.

Additionally, analysts were expecting the company to have higher earnings than what was reported. This caused the stock to decrease in value as investors responded to the news. The company‚Äôs earnings results were met with mixed reactions from analysts and investors. Some analysts were optimistic that the company could turn things around in the future, while others believed the earnings results were indicative of a larger problem. Regardless of how investors and analysts feel about the results, UNIVERSAL HEALTH SERVICES is sure to be watching how their stock performs over the next few months. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for UHS. More…

    Total Revenues Net Income Net Margin
    13.8k 691.54 5.0%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for UHS. More…

    Operations Investing Financing
    1.17k -669.73 -523.97
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for UHS. More…

    Total Assets Total Liabilities Book Value Per Share
    13.73k 7.6k 86.73
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for UHS are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    7.0% -0.9% 7.8%
    FCF Margin ROE ROA
    3.7% 11.1% 4.9%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    GoodWhale has conducted an analysis of the fundamentals of UNIVERSAL HEALTH SERVICES. Our Star Chart gives UNIVERSAL HEALTH SERVICES an impressive score of 8/10 for its cashflows and debt, demonstrating that it is capable to pay off debt and fund future operations. This means that UNIVERSAL HEALTH SERVICES is classified as a ‘cow’, having the track record of paying out consistent and sustainable dividends. As such, investors looking for consistent returns may be interested in UNIVERSAL HEALTH SERVICES. The company’s strength lies in its asset, dividend, and profitability, while its growth remains weak. Despite this, its overall score indicates that investors can expect to see reliable returns from investing in UNIVERSAL HEALTH SERVICES. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    Universal Health Services Inc is one of the leading providers of healthcare services in the United States and its competetitors include Attendo AB, Maternus-Kliniken AG, and Cano Health Inc. These companies provide a wide range of services including primary care, hospital care, mental health services, and more. All of these companies strive to provide quality healthcare to their patients while also focusing on innovative approaches to best serve their communities.

    – Attendo AB ($BER:7AT)

    Attendo AB is a Swedish healthcare provider. It provides a wide range of services, including homecare, daycare, and elderly care services, as well as clinical and diagnostic care. As of 2023, Attendo AB has a market cap of 384.68M, indicating that the company is worth a significant amount to investors. Additionally, its Return on Equity (ROE) is 7.7%, which indicates that the company is generating a healthy return on its shareholders’ investments. These figures suggest that Attendo AB is a sound investment for those looking for a long-term stake in the healthcare industry.

    – Maternus-Kliniken AG ($BER:MAK)

    Maternityus-Kliniken AG is a German-based hospital chain specializing in maternal health and maternity services. Founded in 1938, the company has over 80 years of experience in providing quality healthcare services to mothers and their families. As of 2023, the company has a market capitalization of 37.75M and a Return on Equity of -1.61%. Despite the negative ROE, the company has been able to steadily increase its market capitalization over the past few years as it expands its operations across Germany. Maternityus-Kliniken AG provides comprehensive services to pregnant women and their families, such as prenatal care, childbirth education, and postnatal care. In addition, the company also provides innovative treatments and technologies for fetal monitoring, diagnostics, and interventions.

    – Cano Health Inc ($NYSE:CANO)

    Cano Health Inc is a healthcare services company that provides integrated primary care, specialty care, and ancillary services to the elderly, disabled and chronically ill in the United States. As of 2023, the company had a market capitalization of 295.88 million dollars and a Return on Equity of -68.73%. This shows that the company is not very profitable in terms of returning capital to investors and is struggling to turn profits. This low return on equity suggests that Cano Health Inc may not be a good investment option for investors looking for short-term gains.

    Summary

    Universal Health Services (UHS) reported strong financial results for FY2023 Q2 with total revenue of $3548.1 million and net income of $171.3 million, representing year-over-year increases of 6.8% and 4.4%, respectively. Despite the positive financials, the stock price moved down on the day which could be attributed to either profit taking after recent gains or other internal and external factors. For investors looking to gain exposure to UHS, it may be worth considering the company’s fundamentals and future prospects, including its competitive positioning in the healthcare sector, its growth opportunities, and its overall financial health.

    Recent Posts

    Leave a Comment